top of page

EU 2023/607 MDR Transition Timeline and ÜTS: Final Dates by Class

12 hours ago
5 min read
AB 2023/607 MDR geçiş takvimi ve ÜTS son tarihler
  • SUMMARY

    Regulation (EU) 2023/607 amended the transition provisions of the MDR and extended the period for placing on the market devices certified under the old directives (MDD and AIMDD). The procedure for benefiting from this extension in Türkiye is regulated in the Tenth Section of TİTCK's ÜTS Registration Guideline TCKKD-KLVZ-03.

    In this article we give the final dates by device class as they appear in the guideline (unofficial translations). How the application is made in EBS and ÜTS is the subject of a separate article: MDR time extension application: EBS and ÜTS.

    For your MDR transition period extension application: Medical Device ÜTS Registration Consultancy

    Contents

    1. What Is EU 2023/607?2. Class III Implantable Custom-Made Devices3. Class III and Class IIb Implantable Devices4. Other Class IIb, Class IIa, Class Im and Class Is Devices5. Class I Devices Upclassified Under the MDR6. Extension Conditions: What Must the Manufacturer's Declaration Contain?7. The Situation According to the Document End Date8. How Is the Extension Defined in Türkiye: First EBS, Then ÜTS9. Frequently Asked Questions

    1. What Is EU 2023/607?

    Article 45 of the guideline introduces the Regulation as follows:

    “ARTICLE 45- (1) In order to reduce the risk of shortages of medical devices, the European Commission published "Regulation (EU) 2023/607 of the European Parliament and of the Council amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices" in the Official Journal of the EU on 20 March 2023, and it entered into force.”

    In Türkiye, the same amendments were reflected in the Medical Device Regulation and the In Vitro Diagnostic Medical Device Regulation by the Official Gazette dated 2/4/2023 and numbered 32151.

    2. Class III Implantable Custom-Made Devices

    “(3) Provided that the conditions specified in the Regulation mentioned in the first paragraph of this article are fulfilled, Class-III implantable custom-made devices (ITC) under the MDD may be placed on the market or put into service until 26.05.2026.”

    3. Class III and Class IIb Implantable Devices

    “(4) Provided that the conditions specified in the Regulation mentioned in the first paragraph of this article are fulfilled, Class-III devices under the MDD or AIMDD and Class-IIb implantable devices, except sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors, may be placed on the market or put into service until 31.12.2027.”

    Which date the excluded products in this paragraph are subject to is often confused. For details, see our article on products excluded in the MDR transition.

    4. Other Class IIb, Class IIa, Class Im and Class Is Devices

    “(5) Provided that the conditions specified in the Regulation mentioned in the first paragraph of this article are fulfilled, Class-IIb devices under the MDD, other than those covered by the fourth paragraph of this article, and Class-IIa devices, Class-Im devices and Class-Is devices, may be placed on the market or put into service until 31.12.2028.”

    5. Class I Devices Upclassified Under the MDR

    “(6) Provided that the conditions specified in the Regulation mentioned in the first paragraph of this article are fulfilled, devices for which the conformity assessment procedure under the MDD did not require the involvement of a notified body, for which a declaration of conformity was drawn up before 26 May 2021, and for which the conformity assessment procedure under the MDR requires the involvement of a notified body (devices that were Class-I Other under the MDD but whose class is upgraded under the MDR) may be placed on the market or put into service until 31.12.2028.”

    6. Extension Conditions: What Must the Manufacturer's Declaration Contain?

    The condition for benefiting from the dates is that the manufacturer declares that it meets the extension conditions. The guideline lists the minimum points that must be in this declaration:

    “a) A statement that the relevant device or devices continue to comply with the AIMDD or MDD (whichever regulation applies),”

    “b) A statement that there has been no significant change in the design and intended purpose of the relevant device or devices,”

    “c) A statement that the relevant device or devices do not present an unacceptable risk to the health or safety of patients, users or other persons, or to other aspects of the protection of public health,”

    “ç) A statement that a quality management system (QMS) will be/has been put in place in accordance with MDR Article 10(9), no later than 26.05.2024,”

    The declaration also includes statements that a formal application was made to a notified body by 26.05.2024 and that a written agreement was signed with the notified body by 26.09.2024 (Article 46, fifth paragraph, subparagraphs d and e).

    7. The Situation According to the Document End Date

    The guideline defines different paths according to the end date of the EC certificate. The situation in which the extension is not applied at all is as follows:

    “a) No extension is applied for devices within the scope of an EC certificate issued by an authorized notified body under the MDD or AIMDD whose document end date is before 26.05.2021.”

    For certificates valid on 26.05.2021, an extension is provided according to the application and agreement dates. In applications found appropriate, the validity date of the certificate is extended, in the words of the guideline, "until 31.12.2027 or 31.12.2028, according to the risk class of the device".

    8. How Is the Extension Defined in Türkiye: First EBS, Then ÜTS

    “(7) In order for companies to benefit from the MDR transition provisions for their devices within the scope of the third to sixth paragraphs of this article, they must first make an application through EBS under Article 46 of this Guideline; and afterwards, if the Agency finds their application in EBS appropriate, they must make medical device (and/or document) registration/update applications in ÜTS for the relevant devices and their linked documents under Article 47 of this Guideline.”

    For the step-by-step flow, see: MDR time extension application: EBS and ÜTS.

    9. Frequently Asked Questions

    When did EU 2023/607 enter into force?

    According to the guideline, the Regulation was published in the Official Journal of the EU on 20 March 2023 and entered into force.

    Until what date can Class IIa devices be placed on the market?

    Provided that the conditions are fulfilled, Class IIa devices under the MDD may be placed on the market or put into service until 31.12.2028.

    What is the final date for Class III devices?

    For Class III devices under the MDD or AIMDD, the date is 31.12.2027. For Class III implantable custom-made devices under the MDD, the date is 26.05.2026.

    Is an EC certificate whose end date is before 26.05.2021 extended?

    No. According to the guideline, no extension is applied for devices within the scope of these certificates.

    What is done in Türkiye to benefit from the extension?

    First, "Time Extension Application No. 2023/KK-1" is made through EBS. If the Agency finds the application appropriate, an application is made in ÜTS for the devices and documents.

    For the preparation of your EBS and ÜTS applications: Medical Device ÜTS Registration Consultancy

    Sources

    • TİTCK: ÜTS Registration Guideline TCKKD-KLVZ-03, Tenth Section

    • EUR-Lex: Regulation (EU) 2023/607

 
 

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara